| A review of currently available fenofibrate and fenofibric acid formulations H Ling, JT Luoma, D Hilleman Cardiology research 4 (2), 47, 2013 | 107 | 2013 |
| Tafamidis: a first-in-class transthyretin stabilizer for transthyretin amyloid cardiomyopathy J Park, U Egolum, S Parker, E Andrews, D Ombengi, H Ling Annals of Pharmacotherapy 54 (5), 470-477, 2020 | 49 | 2020 |
| Assessing the elevation of cardiac biomarkers and the severity of COVID-19 infection: a meta-analysis C Walker, S Deb, H Ling, Z Wang Journal of Pharmacy & Pharmaceutical Sciences 23, 396-405, 2020 | 28 | 2020 |
| An Update on the Clinical Development of Proprotein Convertase Subtilisin Kexin 9 Inhibitors, Novel Therapeutic Agents for Lowering Low‐Density Lipoprotein Cholesterol H Ling, TL Burns, DE Hilleman Cardiovascular therapeutics 32 (2), 82-88, 2014 | 24 | 2014 |
| Inclisiran: a first-in-class siRNA therapy for lowering low-density lipoprotein cholesterol E Samuel, M Watford, UO Egolum, DN Ombengi, H Ling, DW Cates Annals of Pharmacotherapy 57 (3), 317-324, 2023 | 23 | 2023 |
| Reducing the risk of obesity: defining the role of weight loss drugs H Ling, TL Lenz, TL Burns, DE Hilleman Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (12 …, 2013 | 23 | 2013 |
| Effect of ezetimibe added to high-intensity statin therapy on low-density lipoprotein cholesterol levels: a meta-analysis J Lee, U Egolum, H Parihar, M Cooley, H Ling Cardiology research 12 (2), 98, 2021 | 21 | 2021 |
| Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction CA Henry, RA Lyon, H Ling Vascular health and risk management, 163-169, 2016 | 21 | 2016 |
| Novel strategies for managing dyslipidemia: treatment beyond statins H Ling, TL Burns, DE Hilleman Postgraduate medicine 124 (6), 43-54, 2012 | 19 | 2012 |
| Opposite trends of glycosides and alkaloids in Dendrobium nobile of different age based on UPLC‐Q/TOF‐MS combined with multivariate statistical analyses A Lu, Y Jiang, J Wu, D Tan, L Qin, Y Lu, Y Qian, C Bai, J Yang, H Ling, ... Phytochemical Analysis 33 (4), 619-634, 2022 | 15 | 2022 |
| Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris H Ling, KA Packard, TL Burns, DE Hilleman American Journal of Cardiovascular Drugs 13, 407-412, 2013 | 11 | 2013 |
| Identification of Pyrrolizidine Alkaloids in Senecio Plants by Liquid Chromatography‐Mass Spectrometry AJ Lu, YL Lu, DP Tan, L Qin, H Ling, CH Wang, YQ He Journal of Analytical Methods in Chemistry 2021 (1), 1957863, 2021 | 9 | 2021 |
| The Effect of Ranolazine on Glycemic Control: A Narrative Review to Define the Target Population D Lisi, E Andrews, C Parry, C Hill, D Ombengi, H Ling Cardiovascular drugs and therapy 33 (6), 755-761, 2019 | 8 | 2019 |
| Lifting coronavirus disease-19 shelter-in-place restrictions: impact on heart failure hospitalizations in Northeast Georgia H Ling, M Fudim, UO Egolum Journal of cardiac failure 26 (9), 806, 2020 | 7 | 2020 |
| P2y12 inhibitor monotherapy after a short dual antiplatelet therapy versus standard-term dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: A … AC Ho, U Egolum, S Parker, J Dimmel, A Hawkins, H Ling Clinical Drug Investigation 40, 799-808, 2020 | 6 | 2020 |
| UPLC-Q/TOF-MS coupled with multivariate analysis for comparative analysis of metabolomic in Dendrobium nobile from different growth altitudes A Lu, L Cao, D Tan, L Qin, Y Lu, Y Zhao, Y Qian, C Bai, J Yang, H Ling, ... Arabian Journal of Chemistry 15 (11), 104208, 2022 | 5 | 2022 |
| Extended duration dual antiplatelet therapy after percutaneous coronary intervention in patients with peripheral arterial disease: a meta-analysis H Ling, E Andrews, D Ombengi, F Li Cardiology Research 9 (3), 137, 2018 | 5 | 2018 |
| Application of single-cell RNA sequencing technology in liver diseases: a narrative review L He, A Lu, L Qin, Q Zhang, H Ling, D Tan, Y He Annals of Translational Medicine 9 (20), 2021 | 4 | 2021 |
| Identification and simultaneous determination of the main toxical pyrrolizidine alkaloids in a compound prescription of traditional Chinese medicine: qianbai biyan tablet M Yang, D Tan, A Lu, L Qin, C Wang, H Ling, Y Lu, Y He International journal of analytical chemistry 2021 (1), 5209618, 2021 | 4 | 2021 |
| Perceptions, knowledge, and patterns of use of" fish oil" products in cardiac patients. EB Hawkins, H Ling, TL Burns, DE Hilleman Pharmacotherapy 32 (10), E184-E184, 2012 | 2 | 2012 |
